Jaimie M. Henderson
Affilliation: Stanford University School of Medicine
Jaimie Henderson, M.D. is director of the Stanford program in Stereotactic and Functional Neurosurgery. Following his residency and fellowship training, he developed the movement disorders surgery program at St. Louis University, where he remained on staff for 7 years. He then moved to the Cleveland Clinic Foundation in 2001, joining their world-class functional neurosurgery program which at the time was the busiest in the US. He has directed the Stereotactic and Functional Neurosurgery program at Stanford since 2004.
During his residency in the early 1990’s, Dr. Henderson was intimately involved with the development of the new field of image-guided surgery. This innovative technology has revolutionized the practice of neurosurgery, allowing for safer and more effective operations with reduced operating time. Dr. Henderson remains one of the world’s foremost experts on the application of image-guided surgical techniques to functional neurosurgical procedures such as the placement of deep brain stimulators for movement disorders, epilepsy, pain, and psychiatric diseases.
Talk Title: BrainGate2: Developing an Intracortical Neural Interface for Restoration of Function for People with Paralysis
Brain-computer interfaces (BCIs) provide a means for people with paralysis to control external devices using decoded neural activity. Many sources of neural signals can be used for BCIs, including electroencephalography, electrocorticography, and neuronal ensembles recorded with dense arrays of microelectrodes. The BrainGate clinical trials have focused on the use of the “Utah” array, consisting of 100 silicon microelectrodes arranged in a 10 x 10 grid four millimeters on a side, attached to a percutaneous pedestal which is firmly anchored to the skull. Using this system, research participants with paralysis are able to control external devices including computer communication systems, robots, and functional electrical stimulation systems. Examples of current and ongoing research in the BrainGate2 trial will be presented.